Not Signed In - [ Disclaimer: The information on GoldBamboo for any particular treatment, medicine, drug, or herbal product might be missing or incomplete, and should never be used as a single source of knowledge. GoldBamboo generally has links to authoritative sites displayed toward the bottom of each topic page under the heading "Resources". ]
Hemophilia |
|
|
Clinical Trial: Efficacy of NovoSeven in Bleeding Prophylaxis in Hemophilia
This study is currently recruiting patients.
|
Purpose
The purpose of this study is to evaluate the effectiveness of secondary prophylactic treatment with NovoSeven in haemophilia A and B patients with inhibitors.
| Condition | Treatment or Intervention | Phase |
|---|---|---|
| Hemophilia A Hemophilia B | Drug: NovoSeven | Phase II |
MedlinePlus related topics: Bleeding Disorders; Blood and Blood Disorders; Genetic Disorders; Hemophilia
Study Type: Interventional
Study Design: Treatment, Randomized, Double-Blind, Uncontrolled, Parallel Assignment, Efficacy Study
Official Title: Exploratory, Multi-centre, Randomised, Double-blind, Uncontrolled Trial Evaluating the Efficacy of Activated Recombinant Factor VII (rFVIIa/NovoSeven) in Secondary Bleeding Prophylaxis in Congenital Haemophilia A or B Patients with Inhibitors
Expected Total Enrollment: 1680
Study start: March 2004; Expected completion: December 2005
Last follow-up: October 2005; Data entry closure: November 2005
Eligibility
Ages Eligible for Study: 2 Years and above, Genders Eligible for Study: Both
Criteria
- Ages Eligible for Study: 2 Years and older
Location and Contact Information
California
Berkeley, California, 94704, United States; Recruiting
Orange, California, 92868, United States; Recruiting
Illinois
Chicago, Illinois, 60612, United States; Recruiting
Indiana
Indianapolis, Indiana, 46260, United States; Recruiting
Iowa
Iowa City, Iowa, 52242, United States; Recruiting
Louisiana
New Orleans, Louisiana, 70112, United States; Recruiting
Massachusetts
Boston, Massachusetts, 02115, United States; Recruiting
Michigan
Detroit, Michigan, 48201, United States; Recruiting
New Jersey
Newark, New Jersey, 07112, United States; Recruiting
New York
New Hyde Park, New York, 11040, United States; Recruiting
Pennsylvania
Philadelphia, Pennsylvania, 19104, United States; Recruiting
Philadelphia, Pennsylvania, 19134, United States; Recruiting
Texas
Houston, Texas, 77030, United States; Recruiting
More Information
Record last reviewed: April 2005
Last Updated: April 18, 2005
Record first received: April 18, 2005
ClinicalTrials.gov Identifier: NCT00108758
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-05-03
Source: ClinicalTrials.gov
Cache Date: May 4, 2005
Resources
- Bleeding Disorders (National Women's Health Information Center)
- Bleeding Disorders: Financial and Insurance Issues (National Hemophilia Foundation)
email this page
print this page
bookmark this page
feedback on this page
